RayCare 2024A Interoperable With Varian TrueBeam
RayCare 2024A Interoperable With Varian TrueBeam
STOCKHOLM, May 16, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce that the oncology information system RayCare* 2024A has been certified to be interoperable with Varian TrueBeam linear accelerators, version 3.0. This is the result of joint testing activities between RaySearch and Varian Medical Systems during 2024.
斯德哥爾摩，2024 年 5 月 16 日 /PRNewswire/-- RaySearch Laboratories AB（publ）自豪地宣佈，腫瘤學信息系統 RayCare* 2024A 已通過認證，可與瓦里安 TrueBeam 互操作 線性加速器，版本 3.0。這是RaySearch和瓦里安醫療系統在2024年聯合測試活動的結果。
In May 2023, RayCare 5B was certified to be interoperable with TrueBeam 3.0. This was 17 months after the release of RayCare 5B. The interoperability certificate for 2024A that was issued now comes already before the release of RayCare 2024A which is scheduled to be finalized in a few weeks from now.
2023 年 5 月，RayCare 5B 獲得認證，可與 TrueBeam 3.0 互操作。這是在 RayCare 5B 發佈後 17 個月。現在頒發的2024A互操作性證書已經在RayCare 2024A發佈之前發佈了，RayCare 2024A計劃在幾周後最終確定。
TrueBeam is Varian's most prevalent treatment delivery platform and has been installed in thousands of radiation therapy clinics in the world since its launch in 2010. It supports all treatment techniques and capabilities that are provided by so called c-arm linacs, including IMRT, VMAT and electrons with flexible beam energy selection and non-coplanar beam arrangements. The interoperability certificate applies to linacs in the TrueBeam family equipped with kV imaging: TrueBeam, TrueBeam STx, Edge and VitalBeam.
TrueBeam 是瓦里安最常用的治療交付平台，自 2010 年推出以來，已安裝在全球數千家放射治療診所中。它支持所謂的 C 型臂直線加速器提供的所有治療技術和能力，包括 IMRT、VMAT 和具有靈活光束能量選擇和非共面光束排列的電子。互操作性證書適用於配備 kV 成像的 TrueBeam 系列直線加速器：TrueBeam、TrueBeam STX、Edge 和 VitalBeam。
Agam Sharda, VP of Product & Portfolio Management at Varian, says: "By achieving clinical interoperability between TrueBeam and RayCare, Varian again shows our commitment to developing, deploying, and maintaining critical interfaces for our fleet to operate seamlessly. RaySearch as an alliance in our ecosystem program is another example of our resolve to meet the diverse needs of customers across the world."
瓦里安產品與產品組合管理副總裁阿加姆·沙爾達表示：“通過實現TrueBeam和RayCare之間的臨床互操作性，瓦里安再次表明了我們致力於開發、部署和維護關鍵接口，使我們的機隊能夠無縫運行。作爲我們生態系統計劃中的一個聯盟，RaySearch是我們決心滿足全球客戶多樣化需求的又一個例子。”
Johan Löf, founder and CEO, RaySearch, says: "Interoperability with treatment delivery systems is a key feature of RayCare and it is gratifying to see that the interoperability of the latest version of RayCare with TrueBeam has been achieved in time for the release and I look forward to clinical implementation of the connection later in 2024."
RaySearch創始人兼首席執行官約翰·洛夫表示：“與治療交付系統的互操作性是RayCare的關鍵特性，令人欣慰的是，最新版本的RayCare與TrueBeam的互操作性已在發佈前及時實現，我期待在2024年晚些時候實現這種連接的臨床實施。”
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]
欲了解更多信息，請聯繫：
約翰·洛夫，RaySearch Laboratories AB（publ）創始人兼首席執行官
電話：+46 (0) 8 510 530 00
[電子郵件保護]
* Subject to regulatory clearance in some markets.
* 須經某些市場的監管許可。
This information was brought to you by Cision
這些信息是由 Cision 帶給你的
The following files are available for download:
以下文件可供下載：
|
RaySearch Press Release May 16, 2024 |
|
RaySearch 新聞稿 2024 年 5 月 16 日 |
SOURCE RaySearch Laboratories
來源 RaySearch 實驗室
